Elena Traistaru
Finanzdirektor/CFO bei Emerald Health Bioceuticals, Inc.
Profil
Elena Traistaru is currently the Chief Financial Officer at Emerald Health Bioceuticals, Inc. and the Corporate Controller at Emerald Health Usa, Inc. She previously worked as the Controller at Enigma Diagnostics Ltd.
from 2010 to 2017, the Chief Financial Officer at Skye Bioscience, Inc. in 2020, and the President & Chief Financial Officer at Et Accounting Consulting from 2017 to 2018.
Ms. Traistaru obtained her undergraduate degree from Bucharest Academy of Economic Studies.
Aktive Positionen von Elena Traistaru
Unternehmen | Position | Beginn |
---|---|---|
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.10.2019 |
Emerald Health Usa, Inc. | Comptroller/Controller/Auditor | 01.11.2018 |
Ehemalige bekannte Positionen von Elena Traistaru
Unternehmen | Position | Ende |
---|---|---|
SKYE BIOSCIENCE, INC. | Finanzdirektor/CFO | 25.09.2020 |
Et Accounting Consulting | Vorstandsvorsitzender | 01.10.2018 |
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom. | Comptroller/Controller/Auditor | 01.02.2017 |
Ausbildung von Elena Traistaru
Bucharest Academy of Economic Studies | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SKYE BIOSCIENCE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Health Technology |
Emerald Health Usa, Inc. | |
Et Accounting Consulting | |
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom. | Health Technology |